TickerFacts.

C4 Therapeutics, Inc. (CCCC): Share Repurchases

Annual figures by period end, from SEC filings.

$193.0K
Year ended 2025-12-31
$238.0K
Trailing 12 months to 2026-06-30
-0.1%
5-year compound annual growth
$194.0K2019-12-31: $30.0K2020-12-31: $194.0K2022-12-31: $02023-12-31: $110.0K2024-12-31: $194.0K2025-12-31: $193.0K$193.0K
2019-12-31 Share Repurchases (USD) 2025-12-31
Period endedShare RepurchasesChange YoYSource filing
2025-12-31$193.0K-0.5%2026-02-26, From 2025-01-01
2024-12-31$194.0K+76.4%2026-02-26, From 2024-01-01
2023-12-31$110.0Kn/a2025-02-27, From 2023-01-01
2022-12-31$0n/a2024-02-22, From 2022-01-01
No annual figure between 2020-12-31 and 2022-12-31.
2020-12-31$194.0K+546.7%2022-02-24, From 2020-01-01
2019-12-31$30.0Kn/a2022-02-24, From 2019-01-01

Share Repurchases at similar companies

Companies with the same SEC industry code (Biological Products, (No Diagnostic Substances)), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShare RepurchasesChange YoY
C4 Therapeutics, Inc. (CCCC)2025-12-31$193.0K-0.5%
Invivyd, Inc. (IVVD)2024-12-31$0-100.0%
Champions Oncology, Inc. (CSBR)2025-04-30$0-100.0%
Pelthos Therapeutics Inc. (PTHS)2025-12-31$0-100.0%
ADMA Biologics, Inc. (ADMA)2025-12-31$31.94Mn/a
Repligen Corp (RGEN)2025-12-31$0n/a
Bio-Techne Corp (TECH)2026-06-30$41.67M-84.9%
Halozyme Therapeutics, Inc. (HALO)2025-12-31$342.37M+36.9%
Prokidney Corp. (PROK)2025-12-31$0n/a

Compare CCCC, IVVD, CSBR, PTHS side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗